Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) syndrome is a rare autosomal dominant genetic disorder, also known as ...

LONDON, GREATER LONDON, UNITED KINGDOM, September 10, 2025 /EINPresswire.com/ -- What Is The Estimated Industry Size Of Breast Cancer Gene (BRCA) Mutations Treatment Market? There has been robust ...

In a breakthrough that reads like a beacon of hope, Russia has announced that its novel cancer vaccine, Enteromix, has demonstrated 100% efficacy and safety in initial human trials. The news ...

Hospitals may soon have a faster option, thanks to a groundbreaking system built in part by Sneha Goenka, an assistant ...

Artificial Intelligence (AI) is leaving a significant imprint on the healthcare sector with its innovative applications, ...

Early immune pressure and co-occurring mutations drive changes in hepatitis C virus fitness and evolution, revealing key dynamics in the establishment of chronic infection.

Recent advancements in DNA analysis have brought to light intriguing evidence that humans may have multiple, uncharted ...

DAWNZERA's FDA approval is expected to be a key hereditary angioedema market driver, given its first-in-class status as an RNA-targeted antisense oligonucleotide therapy. Hereditary angioedema affects ...

A new study by researchers from Montefiore’s Albert Einstein College of Medicine has found that a rare genetic mutation that can lead to serious heart problems is much more common among people of ...

MODEYSO's FDA approval is expected to be a key diffuse midline glioma market driver, given its first-in-class status as a targeted therapy for H3 K27M-mutant tumors.

Scientists have discovered how mutations in a specific gene drive the rare developmental disorder Weaver syndrome, which is marked by intellectual disability and overgrowth and predisposes people with ...

Scientists have discovered how mutations in a specific gene drive the rare developmental disorder Weaver syndrome, which is marked by intellectual disability and overgrowth and predisposes people with ...